Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms |
Target |
Mechanism αvβ6 antagonists(Integrin alpha-V/beta-6 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cholangitis, Sclerosing | Phase 1 | US | 08 Nov 2017 | |
Cholangitis, Sclerosing | Phase 1 | US | 08 Nov 2017 | |
COVID-19 | Phase 1 | US | 08 Nov 2017 | |
COVID-19 | Phase 1 | US | 08 Nov 2017 | |
Pancreatic Carcinoma | Phase 1 | US | 12 Jan 2016 | |
Idiopathic Pulmonary Fibrosis | Phase 1 | - | - | |
Idiopathic Pulmonary Fibrosis | Phase 1 | - | - | |
Idiopathic Pulmonary Fibrosis | Phase 1 | - | - | |
Pancreatic Cancer | Preclinical | - | - | |
Idiopathic Pulmonary Fibrosis | Discovery | US | - | - |